New egg-maturing technique could slash IVF costs and risks

NCT ID NCT06984081

Recruiting now Disease control Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a milder form of IVF called CAPA in-vitro oocyte maturation (IVM). Instead of giving women strong hormones to stimulate egg growth, eggs are collected early and matured in a lab. The goal is to reduce side effects and costs for women with infertility or those preserving fertility before cancer treatment. The trial will enroll 100 women aged up to 50.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CAPA IVM (a procedure where eggs are matured outside the body)
What this could lead to: If successful, this could offer a safer, lower-cost alternative to standard IVF for women with infertility or those needing fertility preservation.
What could go wrong: This is an early-stage study with only 100 participants, so results may not apply to everyone. The procedure may not produce enough mature eggs for successful pregnancy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY, FEMALE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

female infertility

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFERTILITY, FEMALE

Contacts and locations

Locations

Prince of Wales Hospital
RECRUITING

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.